Advent of Better Catheters and Advanced Delivery Systems creates New Avenues in Parenteral Nutrition Market

Published On : Feb 06, 2019 | Category : Pharmaceutical

Parental nutrition has been in clinical practice for critically ill patients for over two and a half decades. In recent years, it has gained wide traction in the healthcare industry to meet the nutritional needs of adult and pediatric patients in the intensive care units. Especially in children, total parental nutrition gathered wide popularity in managing fatal conditions on account of several beneficial effects. A key factor in the evolution of the parenteral nutritional market has been their role in meeting the unmet needs of the patient populations.  It has been found that enteral feeding is not possible or is impractical in such patients due to poor gastrointestinal intolerance. Emerging limitations of enteral feeding in intensive care patients has provided a sweet spot for the demand for parenteral nutrition in the global healthcare systems.

The prospects of the global parenteral nutrition market is vast and one of the recent reports projects the global opportunities to expand at an attractive compound annual growth rate of 4.7% during the assessment period of 2018–2026.

Growing Prevalence of Malnutrition in Critically Ill Patients bolsters Demand

The global parenteral nutrition market has gained increasing momentum from the recent body of systematic research and clinical studies on understanding the mechanism. These studies have shed light on the clinical relevance of parenteral nutrition in intensive care units, where underfeeding and overfeeding are common but of substantial concern. Moreover, the market is witnessing new avenues from relentless efforts being made for improving the techniques of nutrition. To this end, industry players are constantly seeking the use of better catheters and advanced delivery systems.

The rising incidence of infectious diseases and growing prevalence of malnutrition in critically ill patients are key factors propelling the growth of the market. In particular, rising incidence rates of gastro-intestinal disorders and short bowel syndrome is a key trend bolstering lucrative demand for parenteral nutrition. Substantial health burden of chronic kidney diseases is also bears positive impact on the growth dynamic of the market. The advent of better modes of nutrition and their potential clinical benefits have helped in the rapid commercialization of some modes of parenteral nutrition. For instance, the growing relevance of parenteral lipid emulsions is a case in point. Recently, there has been growing rationale for prescribing nutrition in ICU patients, especially given the promising practical benefits that personalized prescription may bring for them.

Growing Number of Product Approvals imparts Momentum to Market

The global parenteral nutrition has also gained large momentum from growing number of product approvals by leading regulatory agencies, especially in developed nations such as by the U.S. Food and Drug Administration (FDA). On the other hand, developing regions hold enormous potential in the global parenteral nutrition market. In particular, the demand for parenteral nutrition is expected to rise at prominent pace. Global health burden of chronic kidney disorders in the region, especially in India and China, is expected to create vast promising avenues in the global market.

The growth is supported by continuous, vast improvements made in quality of life for the regional populations. Increasing access to comprehensive health care to patients is also bolstering the demand for parenteral nutrition among patient populations. Moreover, rapid strides made in the pharmaceutical industry in several emerging economies in the region are expected to boost the parenteral nutritional market. Furthermore, rising rates of preterm birth is expected to create new avenues in the market.